Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
WidePoint Corp
WYY
$101M
| $235K | ﹤0.01% |
90,600
+12,850
| +17% | +$34.9K |
|
3177
Zai Lab
ZLAB
$2.06B
| $235K | ﹤0.01% |
14,700
+3,800
| +35% | +$80K |
|
3178
Albany International
AIN
$2.11B
| $234K | ﹤0.01% |
2,500
-9,700
| -80% | -$890K |
|
3179
Harte-Hanks
HHS
$16.2M
| $234K | ﹤0.01% |
31,300
+1,200
| +4% | +$9.13K |
|
3180
Amkor Technology
AMKR
$12.4B
| $232K | ﹤0.01% |
+7,200
| New | +$228K |
|
3181
Globalstar
GSAT
$10.7B
| $230K | ﹤0.01% |
+10,429
| New | +$253K |
|
3182
CI&T Inc
CINT
$431M
| $229K | ﹤0.01% |
55,400
+8,500
| +18% | +$38.4K |
|
3183
HF Foods Group
HFFG
$80.2M
| $229K | ﹤0.01% |
65,300
+8,700
| +15% | +$38.1K |
|
3184
Lexeo Therapeutics
LXEO
$324M
| $229K | ﹤0.01% |
+14,576
| New | +$228K |
|
|
SASR
3185
DELISTED
Sandy Spring Bancorp Inc
SASR
| $228K | ﹤0.01% |
+9,837
| New | +$231K |
|
|
TEAD
3186
Teads Holding Co
TEAD
$68.7M
| $226K | ﹤0.01% |
57,300
-4,700
| -8% | -$18.8K |
|
|
PCH
3187
DELISTED
PotlatchDeltic
PCH
| $225K | ﹤0.01% |
4,776
-110,431
| -96% | -$5.08M |
|
3188
abrdn Physical Silver Shares ETF
SIVR
$4.02B
| $224K | ﹤0.01% |
9,400
-96,200
| -91% | -$2.15M |
|
|
AOMR
3189
Angel Oak Mortgage REIT
AOMR
$220M
| $223K | ﹤0.01% |
20,800
-12,100
| -37% | -$128K |
|
3190
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.15B
| $223K | ﹤0.01% |
+2,200
| New | +$214K |
|
|
JBIO
3191
Jade Biosciences
JBIO
$1.2B
| $222K | ﹤0.01% |
+214
| New | +$163K |
|
3192
Pluri
PLUR
$16.7M
| $222K | ﹤0.01% |
34,387
+10,587
| +44% | +$65K |
|
|
FTH
3193
Faeth Therapeutics
FTH
$702M
| $222K | ﹤0.01% |
10,550
+3,375
| +47% | +$58.2K |
|
3194
GEN Restaurant Group
GENK
$10.9M
| $221K | ﹤0.01% |
18,900
-2,600
| -12% | -$21.5K |
|
3195
The Oncology Institute
TOI
$486M
| $221K | ﹤0.01% |
140,100
+50,800
| +57% | +$96.6K |
|
3196
Imperial Petroleum
IMPP
$213M
| $220K | ﹤0.01% |
70,400
+7,600
| +12% | +$23.6K |
|
|
ORGN
3197
DELISTED
Origin Materials
ORGN
| $220K | ﹤0.01% |
+14,350
| New | +$249K |
|
3198
Yunhong Green CTI Ltd
YHGJ
$7.54M
| $220K | ﹤0.01% |
13,818
+1
| +0% | +$16 |
|
3199
Rani Therapeutics
RANI
$87M
| $219K | ﹤0.01% |
70,300
+26,600
| +61% | +$91.5K |
|
3200
Tennant Co
TNC
$1.43B
| $219K | ﹤0.01% |
1,800
-55,200
| -97% | -$5.64M |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.